We use survival analysis to analyze the decay in the protection induced by eight SARS-CoV-2 vaccines using data from 33,418 fully anonymized patients from the IMSS public health system in Mexico, incl
The evaluation will be carried out by comparing frequency rates for different indicators in three birth cohorts that did not receive 7-PCV or TIV (1994-1996), in six cohorts that received the vaccines